-
Mashup Score: 3
Join us for an inspiring and heartfelt interview with Melanie Bloom, the beloved wife of the late global news correspondent, David Bloom. In this exclusive c…
Source: www.youtube.comCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Mini PEP Talk: Venous Thromboembolism (VTE) and Heart Health - 7 month(s) ago
Learn from Dr. Alejandra Gutierrez Bernal about how heart disease and reduced cardiac function increase risk for VTE and how VTE can lead to right heart strain.
Source: www.youtube.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
The spectrum of venous thromboembolic (VTE) disease encompasses both acute deep venous thrombosis (DVT) and chronic postthrombotic changes (CPC). A large percen…
Source: journals.sagepub.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Background Emulating randomized controlled trials (RCTs) by real-world evidence (RWE) studies would benefit future clinical and regulatory decision-making by balancing the limitations of RCT. We aimed to evaluate whether the findings from RWE studies can support regulatory decisions derived from RCTs of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with venous thromboembolism (VTE). Methods Five landmark trials (AMPLIFY, RE-COVER II, Hokusai-VTE, EINSTEIN-DVT, and EINSTEIN-PE) of NOACs were emulated using the South Korean nationwide claims database (January 2012 to August 2020). We applied an active comparator and new-user design to include patients who initiated oral anticoagulants within 28 days from their VTE diagnoses. The prespecified eligibility criteria, exposure (each NOAC, such as apixaban, rivaroxaban, dabigatran, and edoxaban), comparator (conventional therapy, defined as subcutaneous heparin followed by warfarin), and the definition of outcomes from RCTs
Source: bmcmedicine.biomedcentral.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 7How I approach the prevention and treatment of thrombotic complications in hospitalized patients - 8 month(s) ago
Associate Editors Hendrickson and Ortel edited a How I Treat series on inpatient consultative hematology. In this timely series of articles, the authors present
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020 - 8 month(s) ago
AbstractAim. To identify the absolute risk, causes, and factors associated with rehospitalization within 1 year of discharge with a pulmonary embolism (PE).Meth
Source: academic.oup.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
In a recent study published in JAMA Dermatology, researchers illuminated a previously unrecognized connection between atopic dermatitis and an elevated risk of developing venous thromboembolism in adulthood.
Source: www.hmpgloballearningnetwork.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0
Background: Venous thromboembolism (VTE) is a known complication of coronavirus disease (COVID-19) in patients requiring hospitalization and intensive care. We …
Source: journals.sagepub.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Background: The natural history of patients with a pacemaker-related upper-extremity deep vein thrombosis (UEDVT) has not been consistently studied. Methods: We…
Source: journals.sagepub.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4
Thieme E-Books & E-Journals
Source: www.thieme-connect.comCategories: Hem/Oncs, Latest HeadlinesTweet
If you need a reason to participate in #WTDay23, check out this powerful interview with Melanie Bloom about the fatal blood clot that her husband suffered. We must improve awareness of #VTE to help prevent life-threatening outcomes! https://t.co/ObHnE97FeL